NIH-funded research R21 grant

Understanding how the Hepatitis Delta Virus replicates

Official title: Dynamics of HDV RNA Synthesis

Funded at Georgetown University · NIH-10875592 · Data updated 2026-11-12

This study is looking at how the Hepatitis Delta Virus (HDV) makes copies of itself in the body, which can help us understand how it causes liver disease and could lead to better treatments for people affected by it.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionGeorgetown University
NIH-funded
Lab location1 site (Washington, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$195,000
NIH project number5R21AI175717-02
Project IDNIH-10875592 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Hepatitis Delta Virus infection, particularly those experiencing severe liver disease.

Less likely to help

Patients with other forms of hepatitis or liver disease not related to HDV may not benefit from this research.

What this research studies

This research investigates the unique replication cycle of the Hepatitis Delta Virus (HDV), which causes severe liver disease. By studying how the virus synthesizes its RNA using the host's RNA polymerase II, the research aims to uncover the mechanisms behind viral RNA production and its impact on disease progression. The team employs advanced tracking tools to monitor the RNA synthesis process, which could lead to insights into how the virus spreads and persists in the body. This understanding may pave the way for developing effective therapies against HDV.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective treatments for Hepatitis Delta Virus infections.

How similar studies have gone: While research on HDV is ongoing, this specific approach to understanding its RNA synthesis is relatively novel and has not been extensively tested.

Where this research is happening

  • Georgetown University
    Washington, United States
    Active

Researchers

  • Principal investigator: Casey, John L — Georgetown University
  • Study coordinator: Casey, John L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.